How is Chédiak-Higashi syndrome (CHS) treated?

Updated: Aug 08, 2019
  • Author: Roman J Nowicki, MD, PhD; Chief Editor: Dirk M Elston, MD  more...
  • Print

A subset of CHS patients presenting with the adult form of the disorder have a muted pigmentary or hematologic presentation while their neurologic symptoms dominate the disease. Patients with this pattern of manifestations might benefit, at least in the short term, from L-dopa, selegiline, trihexyphenidyl, biperiden, or amantadine treatment. [14, 23]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!